HEMOGENYX PHARMPLC (Germany) Price Prediction
| 5HU Stock | EUR 4.14 0.62 13.03% |
Oversold Vs Overbought
48
Oversold | Overbought |
Using HEMOGENYX PHARMPLC hype-based prediction, you can estimate the value of HEMOGENYX PHARMPLC LS 01 from the perspective of HEMOGENYX PHARMPLC response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in HEMOGENYX PHARMPLC to buy its stock at a price that has no basis in reality. In that case, they are not buying HEMOGENYX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
HEMOGENYX PHARMPLC after-hype prediction price | EUR 4.14 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
HEMOGENYX |
HEMOGENYX PHARMPLC After-Hype Price Prediction Density Analysis
As far as predicting the price of HEMOGENYX PHARMPLC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in HEMOGENYX PHARMPLC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of HEMOGENYX PHARMPLC, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
HEMOGENYX PHARMPLC Estimiated After-Hype Price Volatility
In the context of predicting HEMOGENYX PHARMPLC's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on HEMOGENYX PHARMPLC's historical news coverage. HEMOGENYX PHARMPLC's after-hype downside and upside margins for the prediction period are 0.21 and 418.14, respectively. We have considered HEMOGENYX PHARMPLC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
HEMOGENYX PHARMPLC is out of control at this time. Analysis and calculation of next after-hype price of HEMOGENYX PHARMPLC is based on 3 months time horizon.
HEMOGENYX PHARMPLC Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as HEMOGENYX PHARMPLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HEMOGENYX PHARMPLC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with HEMOGENYX PHARMPLC, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
16.17 | 127.54 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.14 | 4.14 | 0.00 |
|
HEMOGENYX PHARMPLC Hype Timeline
HEMOGENYX PHARMPLC is presently traded for 4.14on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. HEMOGENYX is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at 16.17%. %. The volatility of related hype on HEMOGENYX PHARMPLC is about 0.0%, with the expected price after the next announcement by competition of 4.14. About 15.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.01. HEMOGENYX PHARMPLC had not issued any dividends in recent years. The entity had 400:1 split on the 19th of September 2024. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out HEMOGENYX PHARMPLC Basic Forecasting Models to cross-verify your projections.HEMOGENYX PHARMPLC Related Hype Analysis
Having access to credible news sources related to HEMOGENYX PHARMPLC's direct competition is more important than ever and may enhance your ability to predict HEMOGENYX PHARMPLC's future price movements. Getting to know how HEMOGENYX PHARMPLC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how HEMOGENYX PHARMPLC may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SRI | SUN ART RETAIL | 0.00 | 0 per month | 1.77 | 0.27 | 10.53 | (3.85) | 30.77 | |
| MTE | Micron Technology | 0.00 | 0 per month | 2.35 | 0.12 | 5.66 | (3.82) | 19.90 | |
| WN6 | CARSALESCOM | 0.00 | 0 per month | 1.21 | 0.02 | 2.65 | (2.59) | 6.82 | |
| SXC | Sunny Optical Technology | 0.00 | 0 per month | 2.93 | 0.20 | 6.52 | (4.72) | 20.55 | |
| CVB | Computer And Technologies | 0.00 | 0 per month | 0.00 | (0.12) | 4.76 | (5.00) | 10.82 | |
| VHY | Vishay Intertechnology | 0.00 | 0 per month | 1.95 | 0.01 | 3.23 | (3.47) | 15.16 | |
| CNJ | Canon Marketing Japan | 0.00 | 0 per month | 1.52 | 0.03 | 2.29 | (2.70) | 7.24 | |
| TQ4 | FANDIFI TECHNOLOGY P | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HEMOGENYX PHARMPLC Additional Predictive Modules
Most predictive techniques to examine HEMOGENYX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for HEMOGENYX using various technical indicators. When you analyze HEMOGENYX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About HEMOGENYX PHARMPLC Predictive Indicators
The successful prediction of HEMOGENYX PHARMPLC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as HEMOGENYX PHARMPLC LS 01, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of HEMOGENYX PHARMPLC based on analysis of HEMOGENYX PHARMPLC hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to HEMOGENYX PHARMPLC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to HEMOGENYX PHARMPLC's related companies.
Story Coverage note for HEMOGENYX PHARMPLC
The number of cover stories for HEMOGENYX PHARMPLC depends on current market conditions and HEMOGENYX PHARMPLC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that HEMOGENYX PHARMPLC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about HEMOGENYX PHARMPLC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for HEMOGENYX Stock analysis
When running HEMOGENYX PHARMPLC's price analysis, check to measure HEMOGENYX PHARMPLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HEMOGENYX PHARMPLC is operating at the current time. Most of HEMOGENYX PHARMPLC's value examination focuses on studying past and present price action to predict the probability of HEMOGENYX PHARMPLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HEMOGENYX PHARMPLC's price. Additionally, you may evaluate how the addition of HEMOGENYX PHARMPLC to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |